Thoracic Cancer (Dec 2021)

Pembrolizumab provides long‐term survival benefits in advanced non‐small cell lung cancer: The 5‐year outcomes of the KEYNOTE‐024 trial

Fengtan Li,
Xifeng Dong

Affiliations

Fengtan Li: Department of Radiology Tianjin Medical University General Hospital Tianjin China
Xifeng Dong: Department of Hematology Tianjin Medical University General Hospital Tianjin China

DOI: https://doi.org/10.1111/1759-7714.14193
Journal volume & issue: Vol. 12, no. 23
pp. 3085 – 3087

Abstract

No abstracts available.

Published in Thoracic Cancer

ISSN: 1759-7706 (Print); 1759-7714 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://onlinelibrary.wiley.com/journal/17597714

About the journal